Orphan receptor Arp-1 binds to the nucleotide sequence located between TATA box and transcriptional initiation site of the human angiotensinogen gene and reduces estrogen induced promoter activity

Molecular and Cellular Endocrinology

Volumn 148, Issue 1-2, 1999, Pages 79-86

  Narayanan, Chittampalli S ^a   Cui, Yanning ^a   Zhao, Yan Yan ^a   Zhou, Jie ^a   Kumar, Ashok ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Angiotensinogen gene; Arp 1; COUP TF; Estrogen; Transcriptional regulation

Indexed keywords

ANGIOTENSINOGEN; ESTROGEN; ESTROGEN RECEPTOR; NUCLEOSIDE; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CELL STRAIN HEPG2; DNA BINDING; DNA PROTEIN COMPLEX; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REGULATORY MECHANISM; TATA BOX; TRANSCRIPTION REGULATION;

ANGIOTENSINOGEN; ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHLORAMPHENICOL O-ACETYLTRANSFERASE; COUP TRANSCRIPTION FACTOR II; COUP TRANSCRIPTION FACTORS; DNA-BINDING PROTEINS; ESTROGENS; GENES, REPORTER; HUMANS; LIVER NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, ESTROGEN; RECEPTORS, STEROID; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; TATA BOX; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033602180     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00236-6     Document Type: Article

References (23)

1. Arngrimsson R., Purandare S., Connor M. et al. Angiotensinogen: a candidate gene involved in preeclampsia? [letter; comment]. Nat. Genet. 4:1993;114-115.
2. Campbell D.J., Habener J.F. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J. Clin. Invest. 78:1986;31-39.
3. Chang E., Perlman A.J. Multiple hormones regulate angiotensinogen messenger ribonucleic acid levels in a rat hepatoma cell line. Endocrinology. 121:1987;513-519.
4. Clauser E., Gaillard I., Wei L., Corvol P. Regulation of angiotensinogen gene. Am. J. Hypertens. 2:1989;403-410.
5. Coezy E., Auzan C., Lonigro A., Philippe M., Menard J., Corvol P. Effect of mestranol on cell proliferation and angiotensinogen production in HepG2 cells: relation with the cell cycle and action of tamoxifen. Endocrinology. 120:1987;133-141.
6. Cooney A.J., Leng X., Tsai S.Y., O'Malley B.W., Tsai M.J. Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone, and retinoic acid receptors. J. Biol. Chem. 268:1993;4152-4160.
7. Corvol P., Jeunemaitre X., Charru A., Kotelevtsev Y., Soubrier F. Role of the renin-angiotensin system in blood pressure regulation and in human hypertension: new insights from molecular genetics. Recent Prog. Horm. Res. 50:1995;287-308.
8. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic. Acids. Res. 11:1983;1475-1489.
9. Fukamizu A., Takahashi S., Seo M.S., Tada M., Tanimoto K., Uehara S., Murakami K. Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter. J. Biol. Chem. 265:1990;7576-7582.
10. Gaillard I., Clauser E., Corvol P. Structure of human angiotensinogen gene. DNA. 8:1989;87-99.
11. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V. et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:1992;169-180.
12. Jiang J.G., Bell A., Liu Y., Zarnegar R. Transcriptional regulation of the hepatocyte growth factor gene by the nuclear receptors chicken ovalbumin upstream promoter transcription factor and estrogen receptor. J. Biol. Chem. 272:1997;3928-3934.
13. Liu Y., Yang N., Teng C.T. COUP-TF acts as a competitive repressor for estrogen receptor-mediated activation of the mouse lactoferrin gene. Mol. Cell Biol. 13:1993;1836-1846.
14. Mangelsdorf D.J., Kliewer S.A., Kakizuka A., Umesono K., Evans R.M. Retinoid receptors. Recent Prog. Horm. Res. 48:1993;99-121.
15. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
16. Paul M., Wagner J., Dzau V.J. Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J. Clin. Invest. 91:1993;2058-2064.
17. Paulweber B., Sandhofer F., Levy Wilson B. The mechanism by which the human apolipoprotein B gene reducer operates involves blocking of transcriptional activation by hepatocyte nuclear factor 3. Mol. Cell Biol. 13:1993;1534-1546.
18. Reue K., Leff T., Breslow J.L. Human apolipoprotein CIII gene expression is regulated by positive and negative cis-acting elements and tissue-specific protein factors. J. Biol. Chem. 263:1988;6857-6864.
19. Skinner S.L., Lumbers E.R., Symonds E.M. Analysis of changes in the renin-angiotensin system during pregnancy. Clin. Sci. 42:1972;479-488.
20. Wang L.H., Ing N.H., Tsai S.Y., O'Malley B.W., Tsai M.J. The COUP-TFs compose a family of functionally related transcription factors. Gene Expr. 1:1991;207-216.
21. Ward K., Hata A., Jeunemaitre X. et al. A molecular variant of angiotensinogen associated with preeclampsia [see comments]. Nat. Genet. 4:1993;59-61.
22. Zhao Y.Y., Qasba P., Siddiqui M.A., Kumar A. Multiple CCAAT binding proteins regulate the expression of the angiotensinogen gene. Cell Mol. Biol. Res. 39:1993;727-737.
23. Zhao, Y.Y., Zhou, J., Narayanan, C.S., Cui, Y., Kumar, A., 1998. Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension (in press).